AGP Picks
View all

Industry Reporter: Massachusetts
Provided by AGP

Industry Reporter: Massachusetts: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Industry Reporter: Massachusetts.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on May 21, 2026

MadHat Media Formalizes Equity Engineering Partnership with SapientSwift Solutions to Accelerate Global DDARP Deployment
May 21, 2026

MadHat Media Formalizes Equity Engineering Partnership with SapientSwift Solutions to Accelerate Global DDARP Deployment

Indeterminate EIN Presswire
MadHat Media Engages Ricci Capital Partners to Lead Series A Capital Formation
May 21, 2026

MadHat Media Engages Ricci Capital Partners to Lead Series A Capital Formation

Indeterminate EIN Presswire
Choate Expands Intellectual Property Litigation Practice with Former Finnegan Attorney Marta Garcia
May 21, 2026

Choate Expands Intellectual Property Litigation Practice with Former Finnegan Attorney Marta Garcia

Indeterminate EIN Presswire
Influential Women Highlights Lindsay Pope: Driving Procurement Excellence Through Leadership and Innovation
May 21, 2026

Influential Women Highlights Lindsay Pope: Driving Procurement Excellence Through Leadership and Innovation

Indeterminate EIN Presswire
Swiss Water Reports Voting Results from Annual General and Special Meeting of Shareholders
May 21, 2026

Swiss Water Reports Voting Results from Annual General and Special Meeting of Shareholders

Indeterminate GlobeNewswire
Licensing Expo Concludes with Record-Breaking Show Floor and Participation from Cultural Icons, Cementing Status as Global Epicenter for Brand Collaboration
May 21, 2026

Licensing Expo Concludes with Record-Breaking Show Floor and Participation from Cultural Icons, Cementing Status as Global Epicenter for Brand Collaboration

Indeterminate GlobeNewswire
VVC Exploration Corporation Provides Regulatory Update and Clarifies a Previous Incorrect Statement about CYRB
May 21, 2026

VVC Exploration Corporation Provides Regulatory Update and Clarifies a Previous Incorrect Statement about CYRB

Indeterminate GlobeNewswire
ATEC INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Alphatec Holdings, Inc.
May 21, 2026

ATEC INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Alphatec Holdings, Inc.

Indeterminate GlobeNewswire
GEHC INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving GE HealthCare Technologies Inc.
May 21, 2026

GEHC INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving GE HealthCare Technologies Inc.

Indeterminate GlobeNewswire
POET SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of POET Technologies Inc. Investors - Contact Kirby McInerney LLP by June 29, 2026
May 21, 2026

POET SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of POET Technologies Inc. Investors - Contact Kirby McInerney LLP by June 29, 2026

Indeterminate GlobeNewswire
Midland Exploration Completes a $5.3 Million Private Placement
May 21, 2026

Midland Exploration Completes a $5.3 Million Private Placement

Indeterminate GlobeNewswire
Exploration Midland complète un placement privé de 5,3 millions $
May 21, 2026

Exploration Midland complète un placement privé de 5,3 millions $

Indeterminate GlobeNewswire
Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting
May 21, 2026

Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting

Indeterminate GlobeNewswire
Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease
May 21, 2026

Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease

Indeterminate GlobeNewswire
Samba TV Launches Project Gravity, an Independent Data Activation Platform for the Agentic Era
May 21, 2026

Samba TV Launches Project Gravity, an Independent Data Activation Platform for the Agentic Era

Indeterminate GlobeNewswire
Modaxo Enters into Agreement to Acquire the Public Transit Business from Conduent
May 21, 2026

Modaxo Enters into Agreement to Acquire the Public Transit Business from Conduent

Indeterminate GlobeNewswire
nVent to Participate in Upcoming Investor Conference
May 21, 2026

nVent to Participate in Upcoming Investor Conference

Indeterminate GlobeNewswire
Crescent Biopharma Announces Trial in Progress Presentation for ASCEND Study of CR-001, a PD-1 x VEGF Bispecific Antibody, at Upcoming American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
May 21, 2026

Crescent Biopharma Announces Trial in Progress Presentation for ASCEND Study of CR-001, a PD-1 x VEGF Bispecific Antibody, at Upcoming American Society of Clinical Oncology (ASCO) 2026 Annual Meeting

Indeterminate GlobeNewswire
Aktis Oncology Reports First-in-Human Clinical Imaging and Dosimetry Data for AKY-2519 Demonstrating Robust Tumor Uptake and Limited Normal Tissue Exposures in Patients with B7-H3 Expressing Tumors
May 21, 2026

Aktis Oncology Reports First-in-Human Clinical Imaging and Dosimetry Data for AKY-2519 Demonstrating Robust Tumor Uptake and Limited Normal Tissue Exposures in Patients with B7-H3 Expressing Tumors

Indeterminate GlobeNewswire
Lili Latin Dance Celebrates Three Years of Community, Culture and Connection in Boston
May 21, 2026

Lili Latin Dance Celebrates Three Years of Community, Culture and Connection in Boston

Indeterminate EIN Presswire
Show More

Share this page:

Sign up for:

Industry Reporter: Massachusetts

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.